Suppr超能文献

机械通气患者的医院获得性肺炎,Stericath封闭式吸痰系统的前瞻性随机评估。

Nosocomial pneumonia in mechanically ventilated patients, a prospective randomised evaluation of the Stericath closed suctioning system.

作者信息

Combes P, Fauvage B, Oleyer C

机构信息

Département d'Information Médicale et de Santé Publique, Centre Hospitalier de Roanne, France.

出版信息

Intensive Care Med. 2000 Jul;26(7):878-82. doi: 10.1007/s001340051276.

Abstract

OBJECTIVE

To compare the ventilator-associated pneumonia (VAP) incidence rates in mechanically ventilated patients according to the type of endotracheal suctioning (closed versus open).

SETTING

The Neurosurgery Intensive Care Unit of the Grenoble University Hospital, France.

DESIGN

A prospective randomised study performed after a 6-month period of nursing personnel training.

PATIENTS

One hundred four consecutive patients needing mechanical ventilation for more than 48 h were randomised into two groups. To be eligible, patients had to have no active infection or respiratory affection in their passes. In the Stericath group (S+, n = 54), patients were not disconnected from the ventilator during suctioning. The others were routinely managed (S-, n = 50). In both groups patterns of frequency and duration of suctioning were performed according to a standardised protocol.

MEASUREMENTS

The non-adjusted incidence rate of VAP was lower for S+ than for S- (7.32 versus 15.89 per 1000 patient-days, p = 0.07). Multivariate analysis performed using the Cox model showed an adjusted risk of VAP 3.5 times higher in S- (95% CI: 11.00-12.33). The risk being 4.3 higher in patients receiving gastric acid secretion inhibitors (1.08-16.82). In non-censored cases (n = 76) length of ICU stay increased by an average of 16.8 days when VAP was present (p = 0.0008). No adverse effect due to Stericath use was noted and volume of tracheal aspirate was similar between groups (p = 0.178).

CONCLUSION

The use of Stericath reduced the incidence rate of VAP without demonstrating any adverse effect.

摘要

目的

根据气管内吸痰方式(封闭式与开放式)比较机械通气患者的呼吸机相关性肺炎(VAP)发病率。

设置

法国格勒诺布尔大学医院神经外科重症监护病房。

设计

在为期6个月的护理人员培训后进行的一项前瞻性随机研究。

患者

104例连续需要机械通气超过48小时的患者被随机分为两组。符合条件的患者在其过往病史中不得有活动性感染或呼吸道疾病。在Stericath组(S +,n = 54)中,患者在吸痰期间不与呼吸机断开连接。其他患者按常规处理(S -,n = 50)。两组均根据标准化方案进行吸痰频率和持续时间的模式操作。

测量

S +组的VAP未调整发病率低于S -组(每1000患者日分别为7.32和15.89,p = 0.07)。使用Cox模型进行的多变量分析显示,S -组的VAP调整风险高3.5倍(95%CI:11.00 - 12.33)。接受胃酸分泌抑制剂的患者风险高4.3倍(1.08 - 16.82)。在非删失病例(n = 76)中,发生VAP时ICU住院时间平均增加16.8天(p = 0.0008)。未观察到使用Stericath的不良反应,两组之间气管吸出物量相似(p = 0.178)。

结论

使用Stericath可降低VAP发病率,且未显示任何不良反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验